Yvonne Greenstreet, Chief Executive Officer at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 1,685 shares at $253.37 ($429K) on 2025-02-14, disclosed to the SEC on 2025-02-18.
Open-market sale of $429k ALNY by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $252.50 | 271 | $68K | 15.9% |
| 2 | $252.50 | 271 | $68K | 15.9% |
| 3 | $253.37 | 300 | $76K | 17.7% |
| 4 | $254.35 | 201 | $51K | 11.9% |
| 5 | $254.35 | 201 | $51K | 11.9% |
| 6 | $255.56 | 85 |
| $22K |
| 5.1% |
| 7 | $256.29 | 98 | $25K | 5.9% |
| 8 | $257.51 | 47 | $12K | 2.8% |
| 9 | $258.07 | 59 | $15K | 3.5% |
| 10 | $259.72 | 21 | $5K | 1.3% |
| 11 | $260.57 | 38 | $10K | 2.3% |
| 12 | $261.45 | 47 | $12K | 2.9% |
| 13 | $263.33 | 21 | $6K | 1.3% |
| 14 | $264.87 | 25 | $7K | 1.5% |
| Total | $254.65 avg | 1,685 | $429K | 100% |
| Filing → |
| ALNY | SELL | 2026-02-17 | $2.2M | — | Filing → |
| ALNY | SELL | 2026-01-14 | $3.5M | — | Filing → |
| ALNY | SELL | 2025-11-14 | $23.2M | — | Filing → |